Description

Tirzepatide is a synthetic peptide-based compound engineered to activate both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In clinical and experimental research, it has been studied for its effects on glucose regulation, insulin signaling, appetite-related pathways, and energy metabolism. Its dual-receptor activity provides a useful framework for investigating the interaction between incretin signaling, metabolic control, and broader endocrine processes.